Economic Evaluation of Talimogene Laherparepvec Plus Ipilimumab Combination Therapy in Patients With Advanced Unresectable Melanoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Economic Evaluation of Talimogene Laherparepvec Plus Ipilimumab Combination Therapy vs Ipilimumab Monotherapy in Patients With Advanced Unresectable Melanoma
JAMA Dermatol 2018 Nov 21;[EPub Ahead of Print], AR Almutairi, NS Alkhatib, M Oh, C Curiel-Lewandrowski, HM Babiker, LD Cranmer, A McBride, I AbrahamFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.